Untitled

• title: a federated platform for patient research data - PMC url: https://pmc.ncbi.nlm.nih.gov/articles/PMC8922179/
• title: Bitfount | Federated AI and Data Science Platform url: https://www.bitfount.com/
• title: 'Please cite this article in press as: A.J.. Williams, et al., Open PHACTS: semantic interoperability for drug discovery, Drug Discov Today (2012), http://dx.doi.org/10.1016/' url: https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=009a966a3dc03da801c0ffdd5c54b74c4fa10f98
• title: Lifebit url: https://lifebit.ai/
• title: Fed-BioMed | Collaborative learning in healthcare url: https://fedbiomed.org/
• title: BioThinkHub - Federated AI Data Platform for Clinical Trials url: https://www.thinkbio.ai/biothinkhub/
• title: How the pharma industry built a common framework for medicinal ... url: https://pistoiaalliance.org/news/how-the-pharma-industry-built-a-common-framework-for-medicinal-product-data/
• title: Data First ! - OntoCommons url: https://ontocommons.eu/sites/default/files/2023-06/Martin%20Romacker_Nick%20Perry_FAIR%20Principles%20implementation%20at%20Roche.pdf
• title: datma - Harness the Full Value of Your Multimodal Healthcare ... url: https://www.datma.com/
• title: Kakao Healthcare Federated Learning Case Study | Google Cloud url: https://cloud.google.com/customers/kakao-healthcare-federated-learning
• title: Global Real-World Data Network | Federated Health Data url: https://trinetx.com/data/
• title: nSights url: https://nference.com/nsights
• title: The Pistoia Alliance Pharma General Ontology url: https://ceur-ws.org/Vol-4196/paper_3.pdf
• title: Delivering Data Driven Value url: https://pistoiaalliance.org/resource-tag/delivering-data-driven-value/
• title: Webinars - EuroBloodNet url: https://eurobloodnet.eu/media/upload/pdf/GENOMED4ALL_Data%20standardization%20and%20linkage%20(Standards%20&%20Federation)_1697033139.pdf date: '2026-09-22' mood: amused scheduled_publish_at: '2026-09-22T12:00:00+03:00' status: published summary: 'Everyone is selling a platform that can move clinical and scientific data around. The harder question is whether the assay, sample, study, and material keep their meaning after they cross one more boundary, because that is where pharma workflows either hold together or quietly collapse.

A lot of the current excitement around federated data makes sense on the surface. Recent clinical and biomedical platforms are leaning harder into distributed access, shared metadata, secure federation, and analysis without bulk movement, while industry semantic work on IDMP and the Pharma General Ontology is trying to pin down shared vocabulary for medicinal products and core R&D concepts. Good. The ceiling has been too low for too long.

But the real failure shows up in the gap between naming and deciding. A team can register a dataset, map columns, and boast about FAIR compliance, then still lose the thread when a scientist asks whether two assay records describe the same material, whether a sample was preprocessed in the same way, or whether a study object refers to a protocol, a cohort, or a run artifact. The software looks orderly. The decision path does not.

I keep thinking about the old habit of calling every export an integration layer. Cute, in a tragic sort of way. An export format can move tokens, but it cannot rescue identity when one system treats a material as a batch concept, another as a reagent instance, and a third as a line in a clinical development platform that only knows how to preserve the shape of a table. Then everyone wonders why the query returns data and still answers nothing.

Federated scientific data only works when the shared thing is meaning itself. That is why the recent emphasis on shared metadata, controlled vocabularies, public URIs, and semantic interoperability matters more than the dashboard theater that usually gets the budget. If a site can expose data but cannot tell you what the entity is, the federation is just a polite queue of mismatched nouns.

The place where this gets expensive is the handoff between R&D, clinical, and manufacturing systems. R&D wants concepts stable enough for discovery and reanalysis. Clinical wants traceable study objects and governed access across sites. Manufacturing wants material identity that survives quality, release, and regulatory inspection. Those three worlds meet at the same sentence, then spend six months disagreeing about what the sentence refers to.

One morning in a lab, a scientist reruns a search against a federated repository and gets three samples that look equivalent until the provenance trail breaks at the map from local label to shared concept. The data moved. The meaning did not. That is the whole problem, dressed in a nicer UI than it deserves.

Interoperability starts with identity, not export formats. The identifier has to carry the same referent across systems, and the ontology has to make that referent explicit enough that software can reason over it instead of merely displaying it. Everything else is decoration around a broken noun.

If this sounds unromantic, good. Infrastructure should be unromantic right up until a trial signal, a release decision, or a cross site analysis depends on it. If you want the nouns to survive contact with reality, write them down properly, then make the systems behave like they mean it. If that needs help, hello@example.com is there for the calm version of the conversation.' tags: - technology-trends - semantic-data - interoperability - data-integration title: The Identity That Survives the Export type: technology_trends